Cohance Lifesciences Limited (BOM:543064)
536.50
+5.30 (1.00%)
At close: Dec 12, 2025
Cohance Lifesciences Market Cap
Cohance Lifesciences has a market cap or net worth of 204.98 billion as of December 12, 2025. Its market cap has decreased by -37.44% in one year.
Market Cap
204.98B
Enterprise Value
206.85B
Revenue
12.11B
Ranking
n/a
PE Ratio
115.81
Stock Price
536.50
Market Cap Chart
Since March 9, 2020, Cohance Lifesciences's market cap has increased from 33.71M to 204.98B, an increase of 608,057.47%. That is a compound annual growth rate of 353.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 204.98B | -29.29% |
| Dec 31, 2024 | 289.89B | 57.55% |
| Dec 29, 2023 | 184.00B | 46.05% |
| Dec 30, 2022 | 125.98B | 0.33% |
| Dec 31, 2021 | 125.56B | 9.05% |
| Dec 31, 2020 | 115.14B | 341,510.23% |
| Mar 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Reliance Industries | 21.06T |
| HDFC Bank | 15.41T |
| Bharti Airtel | 12.48T |
| Tata Consultancy Services | 11.65T |
| ICICI Bank | 9.76T |
| State Bank of India | 8.89T |
| Infosys | 6.63T |
| Bajaj Finance | 6.32T |